Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer de la vessie - TOP -116 des médecins

Spécialisée en virothérapie – un domaine de pointe de l'immunologie – le Dr Inta Jaunalksne apporte plus de 30 ans d'expérience au traitement du cancer de la vessie à la Clinique Pallas.

• Chef du Centre d'immunologie clinique de l'Hôpital universitaire clinique Pauls Stradiņš
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les approches immunologiques innovantes pour le traitement du cancer

Le Dr Yurdakul est spécialisé en uro-oncologie, avec une formation avancée de la Cleveland Clinic Ohio et de l'Université de Pittsburgh, se concentrant sur les traitements du cancer de la vessie.

• Plus de 17 ans d'expérience en urologie et uro-oncologie
• Publication de 16 articles scientifiques internationaux et 58 nationaux
• Formation en chirurgie microvasculaire à l'Université Mercy
• Conférencier et président de session lors de réunions nationales d'urologie

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le professeur Jablonski-Perec a été formée au Sloan-Kettering Cancer Center, l'un des meilleurs établissements d'oncologie au monde, et dirige l'Institut d'oncologie du centre médical Hadassah.

• Diriger le centre de traitement du cancer du sein depuis 1998
• Professeur d'oncologie à l'Université hébraïque
• Membre de plusieurs communautés internationales de cancérologie
• Recevoir une bourse de la faculté de médecine de l'Hadassah

Le professeur Gofrit est certifié pour pratiquer la chirurgie robotique des cancers urologiques. Il dirige le département d'urologie du centre médical Hadassah.

• Suivre une formation spécialisée en oncologie urologique à Chicago, États-Unis
• Rechercher et traiter spécifiquement les cancers de la vessie et du rein
• Enseigner la chirurgie urologique à l'Université hébraïque
• Détenir des prix nationaux et internationaux pour ses travaux en urologie
• Se spécialiser dans la chirurgie endoscopique et assistée par robot da Vinci

Le Dr Amiel est le chef du service d'urologie du centre médical Rambam, spécialisé dans la chirurgie du cancer. Son rôle témoigne d'une expertise approfondie dans les cas urologiques complexes.

• Se spécialiser comme oncochirurgien pour les cancers de l'appareil urinaire
• Fournir des soins dans un grand hôpital universitaire en Israël

Michael Van Kampen est un spécialiste en radiothérapie dévoué, possédant une vaste expérience dans le traitement des cancers urologiques tels que le cancer de la vessie.

• Des années de pratique clinique ciblée en radio-oncologie
• Appliquer des techniques de radiothérapie ciblée pour traiter les cellules cancéreuses
• Travailler à la clinique spécialisée Nordwest à Francfort
• Membre d'une équipe multidisciplinaire pour une prise en charge globale du cancer

Le Prof. Dr Eduard Becht apporte 41 ans d'expérience en urologie et un doctorat honoris causa à son travail à la Clinique Nordwest. Son expertise s'étend des traitements mini-invasifs aux chirurgies complexes de conservation des organes.

• Se spécialiser en uro-oncologie et en urologie reconstructive
• Recevoir un doctorat honoris causa de l'Université Kapodistrias d'Athènes
• Présider l'association Interdisciplinary Urooncology Frankfurt
• Publier plus de 100 articles scientifiques sur les pathologies urologiques
• Enseigner à l'Université Goethe de Francfort depuis 1994

Le Dr Yutkin a plus de 20 ans d'expérience en diagnostic et traitement au centre médical Hadassah.

• Diplômé de la faculté de médecine de l'Université hébraïque de Jérusalem
• Spécialisé dans les troubles de l'articulation temporo-mandibulaire
• Parle couramment l'anglais, l'hébreu et le russe

Urologiste, chirurgien

Chef du département d'urologie de Samsung – le Dr Choi Han Yong est spécialisé dans le traitement du cancer de la vessie au Samsung Medical Center.

• Oncochirurgien spécialisé dans les cancers urologiques
• Diriger un département d'urologie de premier plan
• Expérimenté dans les procédures avancées du cancer de la vessie

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Radiothérapeute spécialisé dans le traitement du cancer de la vessie au centre médical Assuta.

• Spécialisé en radiothérapie
• Avoir de l'expérience dans le traitement de diverses pathologies oncologiques
• Pratiquer des approches thérapeutiques fondées sur des preuves

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Spécialiste en onco-urologie – se concentre exclusivement sur le cancer de la vessie au centre médical Assuta.

• Urologue possédant une expertise approfondie dans le traitement du cancer de la vessie
• Travaille au centre médical Assuta – un établissement d'oncologie de premier plan
• Dédié à l'onco-urologie, garantissant des soins spécialisés

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.